The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four‐year study
Open accessAbstract
Objective: The aim of this work was to determine whether atrophy of specific retinal layers and brain substructures are associated over time, in order to further validate the utility of optical coherence tomography (OCT) as an indicator of neuronal tissue damage in patients with multiple sclerosis (MS). Methods: Cirrus high‐definition OCT (including automated macular segmentation) was performed in 107 MS patients biannually (median follow‐up: 46 months). Three‐Tesla magnetic resonance imaging brain scans (including brain‐substructure volumetrics) were performed annually. Individual‐specific rates of change in retinal and brain measures (estimated with linear regression) were correlated, adjusting for age, sex, disease duration, and optic neuritis (ON) history. Results: Rates of ganglion cell + inner plexiform layer (GCIP) and whole‐brain (r = 0.45; p < 0.001), gray matter (GM; r = 0.37; p < 0.001), white matter (WM; r = 0.28; p = 0.007), and thalamic (r = 0.38; p < 0.001) atrophy were associated. GCIP and whole‐brain (as well as GM and WM) atrophy rates were more strongly associated in progressive MS (r = 0.67; p < 0.001) than relapsing‐remitting MS (RRMS; r = 0.33; p = 0.007). However, correlation between rates of GCIP and whole‐brain (and additionally GM and WM) atrophy in RRMS increased incrementally with step‐wise refinement to exclude ON effects; excluding eyes and then patients (to account for a phenotype effect), the correlation increased to 0.45 and 0.60, respectively, consistent with effect modification. In RRMS, lesion accumulation rate was associated with GCIP (r = −0.30; p = 0.02) and inner nuclear layer (r = −0.25; p = 0.04) atrophy rates. Interpretation: Over time GCIP atrophy appears to mirror whole‐brain, and particularly GM, atrophy, especially in progressive MS, thereby reflecting underlying disease progression. Our findings support OCT for clinical monitoring and as an outcome in investigative trials. Ann Neurol 2015;78:Ann Neurol 2015;78:679–696
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
New Multiple Sclerosis Phenotypic Classification
Lublin, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,259
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment
Tewarie, P., Balk, L., Costello, F., Green, A., Martin, R., Schippling, S., & Petzold, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034823 · Cited by 627
Quantifying axonal loss after optic neuritis with optical coherence tomography
Costello, F., Coupland, S., Hodge, W., Lorello, G. R., Koroluk, J., Pan, Y. I., Freedman, M. S., Zackon, D. H., & Kardon, R. H. (2006) · Annals of Neurology · doi:10.1002/ana.20851 · Cited by 610
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis
Petzold, A., de Boer, J. F., Schippling, S., Vermersch, P., Kardon, R., Green, A., Calabresi, P. A., & Polman, C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70168-x · Cited by 596
Self-citationCalabrese, M., Agosta, F., Rinaldi, F., Mattisi, I., Grossi, P., Favaretto, A., Atzori, M., Bernardi, V., Barachino, L., Rinaldi, L., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.174 · Cited by 555
Evidence of Axonal Damage in the Early Stages of Multiple Sclerosis and Its Relevance to Disability
De Stefano, N., Narayanan, S., Francis, G. S., Arnaoutelis, R., Tartaglia, M. C., Antel, J. P., Matthews, P. M., & Arnold, D. L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.1.65 · Cited by 505
Kappos, L., Moeri, D., Radue, E. W., Schoetzau, A., Schweikert, K., Barkhof, F., Miller, D., Guttmann, C. R., Weiner, H. L., Gasperini, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03053-0 · Cited by 499
Green, A. J., McQuaid, S., Hauser, S. L., Allen, I. V., & Lyness, R. (2010) · Brain · doi:10.1093/brain/awq080 · Cited by 487
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
Gordon-Lipkin, E., Chodkowski, B., Reich, D. S., Smith, S. A., Pulicken, M., Balcer, L. J., Frohman, E. M., Cutter, G., & Calabresi, P. A. (2007) · Neurology · doi:10.1212/01.wnl.0000295995.46586.ae · Cited by 419
Self-citationEight-year follow-up study of brain atrophy in patients with MS
Fisher, E., Rudick, R. A., Simon, J. H., Cutter, G., Baier, M., Lee, J. C., Miller, D., Weinstock-Guttman, B., Mass, M. K., Dougherty, D. S., et al. (2002) · Neurology · doi:10.1212/01.wnl.0000036271.49066.06 · Cited by 374
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis
Talman, L. S., Bisker, E. R., Sackel, D. J., Long, D. A., Galetta, K. M., Ratchford, J. N., Lile, D. J., Farrell, S. K., Loguidice, M. J., Remington, G., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22005 · Cited by 366
Self-citationOptical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis
Syc, S. B., Saidha, S., Newsome, S. D., Ratchford, J. N., Levy, M., Ford, E., Crainiceanu, C. M., Durbin, M. K., Oakley, J. D., Meyer, S. A., et al. (2012) · Brain · doi:10.1093/brain/awr264 · Cited by 348
Self-citationPrimary retinal pathology in multiple sclerosis as detected by optical coherence tomography
Saidha, S., Syc, S. B., Ibrahim, M. A., Eckstein, C., Warner, C. V., Farrell, S. K., Oakley, J. D., Durbin, M. K., Meyer, S. A., Balcer, L. J., et al. (2011) · Brain · doi:10.1093/brain/awq346 · Cited by 333
Self-citationA topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions
Shiee, N., Bazin, P.-L., Ozturk, A., Reich, D. S., Calabresi, P. A., & Pham, D. L. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.09.005 · Cited by 331
Self-citationMicrocystic macular oedema in multiple sclerosis is associated with disease severity
Gelfand, J. M., Nolan, R., Schwartz, D. M., Graves, J., & Green, A. J. (2012) · Brain · doi:10.1093/brain/aws098 · Cited by 331
Optical coherence tomography: a window into the mechanisms of multiple sclerosis
Frohman, E. M., Fujimoto, J. G., Frohman, T. C., Calabresi, P. A., Cutter, G., & Balcer, L. J. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0950 · Cited by 326
Self-citationSaidha, S., Sotirchos, E. S., Ibrahim, M. A., Crainiceanu, C. M., Gelfand, J. M., Sepah, Y. J., Ratchford, J. N., Oh, J., Seigo, M. A., Newsome, S. D., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70213-2 · Cited by 299
Self-citationSormani, M. P., Arnold, D. L., & De Stefano, N. (2014) · Annals of Neurology · doi:10.1002/ana.24018 · Cited by 297
Saidha, S., Syc, S. B., Durbin, M. K., Eckstein, C., Oakley, J. D., Meyer, S. A., Conger, A., Frohman, T. C., Newsome, S., Ratchford, J. N., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511418630 · Cited by 296
Self-citationTrans‐synaptic axonal degeneration in the visual pathway in multiple sclerosis
Gabilondo, I., Martínez‐Lapiscina, E. H., Martínez‐Heras, E., Fraga‐Pumar, E., Llufriu, S., Ortiz, S., Bullich, S., Sepulveda, M., Falcon, C., Berenguer, J., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24030 · Cited by 255
Cortical atrophy is relevant in multiple sclerosis at clinical onset
Calabrese, M., Atzori, M., Bernardi, V., Morra, A., Romualdi, C., Rinaldi, L., McAuliffe, M. J. M., Barachino, L., Perini, P., Fischl, B., et al. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0503-6 · Cited by 237
CRUISE: Cortical reconstruction using implicit surface evolution
Han, X., Pham, D. L., Tosun, D., Rettmann, M. E., Xu, C., & Prince, J. L. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.043 · Cited by 237
Self-citationSiger, M., Dzięgielewski, K., Jasek, L., Bieniek, M., Nicpan, A., Nawrocki, J., & Selmaj, K. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0985-5 · Cited by 236
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning
Ratchford, J. N., Saidha, S., Sotirchos, E. S., Oh, J. A., Seigo, M. A., Eckstein, C., Durbin, M. K., Oakley, J. D., Meyer, S. A., Conger, A., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827b1a1c · Cited by 235
Self-citationDistribution of plaques in seventy autopsy cases of multiple sclerosis in the United States
IKUTA, F., & ZIMMERMAN, H. M. (1976) · Neurology · doi:10.1212/wnl.26.6_part_2.26 · Cited by 234
Spatial decision forests for MS lesion segmentation in multi-channel magnetic resonance images
Geremia, E., Clatz, O., Menze, B. H., Konukoglu, E., Criminisi, A., & Ayache, N. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.03.080 · Cited by 231
Saidha, S., Sotirchos, E. S., Oh, J., Syc, S. B., Seigo, M. A., Shiee, N., Eckstein, C., Durbin, M. K., Oakley, J. D., Meyer, S. A., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.573 · Cited by 230
Self-citationRETINAL PATHOLOGIC CHANGES IN MULTIPLE SCLEROSIS
KERRISON, J. B., FLYNN, T., & GREEN, W. R. (1994) · Retina · doi:10.1097/00006982-199414050-00010 · Cited by 173
Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis
Grazioli, E., Zivadinov, R., Weinstock-Guttman, B., Lincoff, N., Baier, M., Wong, J. R., Hussein, S., Cox, J. L., Hojnacki, D., & Ramanathan, M. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.10.020 · Cited by 168
Reich, D. S., Smith, S. A., Gordon-Lipkin, E. M., Ozturk, A., Caffo, B. S., Balcer, L. J., & Calabresi, P. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.107 · Cited by 167
Self-citationShindler, K. S., Ventura, E. S., Dutt, M., & Rostami, A. M. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.05.017 · Cited by 153
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica
Sotirchos, E. S., Saidha, S., Byraiah, G., Mealy, M. A., Ibrahim, M., Sepah, Y. J., Newsome, S. D., Ratchford, J. N., Frohman, E. M., Balcer, L. J., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828c2f7a · Cited by 148
Self-citationAssociation of Retinal and Macular Damage with Brain Atrophy in Multiple Sclerosis
Dörr, J., Wernecke, K. D., Bock, M., Gaede, G., Wuerfel, J. T., Pfueller, C. F., Bellmann–Strobl, J., Freing, A., Brandt, A. U., & Friedemann, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018132 · Cited by 146
Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis
Miller, D. H. (2004) · NeuroRx · doi:10.1602/neurorx.1.2.284 · Cited by 138
Topology-Preserving Tissue Classification of Magnetic Resonance Brain Images
Bazin, P., & Pham, D. L. (2007) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2007.893283 · Cited by 129
Self-citationKaufhold, F., Zimmermann, H. G., Schneider, E., Ruprecht, K., Paul, F., Oberwahrenbrock, T., & Brandt, A. U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071145 · Cited by 124
Toussaïnt, D., Périer, O., Verstappen, A., & Bervoets, S. (1983) · PubMed · Cited by 122
Zimmermann, H. G., Freing, A., Kaufhold, F., Gaede, G., Bohn, E., Bock, M., Oberwahrenbrock, T., Young, K. L., Dörr, J., Wuerfel, J. T., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512457844 · Cited by 122
Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis
Shiee, N., Bazin, P., Zackowski, K., Farrell, S. K., Harrison, D., Newsome, S., Ratchford, J., Caffo, B., Calabresi, P., Pham, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037049 · Cited by 119
Self-citationReproducibility of high-resolution optical coherence tomography in multiple sclerosis
Syc‐Mazurek, S. B., Warner, C. V., Hiremath, G. S., Farrell, S. K., Ratchford, J. N., Conger, A., Frohman, T. C., Cutter, G., Balcer, L. J., Frohman, E. M., et al. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510371640 · Cited by 114
Self-citationSimple paradigm for extra-cerebral tissue removal: Algorithm and analysis
Carass, A., Cuzzocreo, J. L., Wheeler, M. B., Bazin, P., Resnick, S. M., & Prince, J. L. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.03.045 · Cited by 114
Self-citationBarboni, P., Carelli, V., Savini, G., Carbonelli, M., Morgia, C. L., & Sadun, A. A. (2013) · Brain · doi:10.1093/brain/awt014 · Cited by 113
Brain atrophy in multiple sclerosis: what we know and would like to know
Simon, J. H. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506070823 · Cited by 89
Pfueller, C. F., Brandt, A. U., Schubert, F., Bock, M., Walaszek, B., Waiczies, H., Schwenteck, T., Dörr, J., Bellmann–Strobl, J., Mohr, C. H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018019 · Cited by 83
Warner, C. V., Syc‐Mazurek, S. B., Stankiewicz, A., Hiremath, G. S., Farrell, S. K., Crainiceanu, C. M., Conger, A., Frohman, T. C., Bisker, E. R., Balcer, L. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022947 · Cited by 72
Self-citationYoung, K. L., Brandt, A. U., Petzold, A., Reitz, L. Y., Lintze, F., Paul, F., Martinꝉ, R., & Schippling, S. (2013) · European Journal of Neurology · doi:10.1111/ene.12070 · Cited by 64
Association between MRI parameters and the MS severity scale: a 12 year follow-up study
Minneboo, A., Uitdehaag, B. M. J., Jongen, P. J. H., Vrenken, H., Knol, D., van Walderveen, M., Polman, C. H., Castelijns, J. A., & Barkhof, F. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509102617 · Cited by 42
Progressive Multiple Sclerosis and Gray Matter Pathology: An MRI Perspective
Inglese, M., Oesingmann, N., Casaccia, P., & Fleysher, L. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20247 · Cited by 38
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Cited by
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491
Self-citationRetinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
Petzold, A., Balcer, L. J., Calabresi, P. A., Costello, F., Frohman, T. C., Frohman, E. M., Martinez-Lapiscina, E. H., Green, A. J., Kardon, R., Outteryck, O., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30278-8 · Cited by 585
Self-citationMartinez-Lapiscina, E. H., Arnow, S., Wilson, J. A., Saidha, S., Preiningerova, J. L., Oberwahrenbrock, T., Brandt, A. U., Pablo, L. E., Guerrieri, S., Gonzalez, I., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00068-5 · Cited by 332
Self-citationProgressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
Ontaneda, D., Thompson, A. J., Fox, R. J., & Cohen, J. A. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31320-4 · Cited by 298
Nolan‐Kenney, R. C., Liu, M., Akhand, O., Calabresi, P. A., Paul, F., Petzold, A., Balk, L., Brandt, A. U., Martínez‐Lapiscina, E. H., Saidha, S., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25462 · Cited by 164
Self-citation
Metadata
- Authors
- Saidha, S., Al‐Louzi, O., Ratchford, J. N., Bhargava, P., Oh, J., Newsome, S. D., Prince, J. L., Pham, D., Roy, S., van Zijl, P., Balcer, L. J., Frohman, E. M., Reich, D. S., Crainiceanu, C., & Calabresi, P. A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2015-10
- Volume
- 78
- Issue
- 5
- Pages
- 801-813
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1828579964
- Cited by
- 391
- References
- 53
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.